Login / Signup

Faricimab phase 3 DME trial significance of personalized treatment intervals (PTI) regime for future DME trials.

Ashish SharmaNilesh KumarNikulaa ParachuriDhatri KaranamBaruch D KuppermannFrancesco Maria BandelloCarl D Regillo
Published in: Eye (London, England) (2021)
Keyphrases
  • clinical trial
  • phase iii
  • current status